A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

NCT05437263 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)

NCT06978725 ·Status: RECRUITING ·Phase: PHASE2

A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

NCT05188521 ·Status: COMPLETED ·Phase: PHASE2

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

NCT02933866 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

NCT02932462 ·Status: COMPLETED ·Phase: PHASE3

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

NCT05030415 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

NCT01708603 ·Status: TERMINATED ·Phase: PHASE3

The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis

NCT06833307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

NCT05593432 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

NCT02872285 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)

NCT01871402 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

NCT03418493 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

NCT03706209 ·Status: COMPLETED ·Phase: PHASE2

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

NCT03210961 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus

NCT05593445 ·Status: COMPLETED ·Phase: PHASE2

Cellular and Molecular Biomarkers in Patients With Lichen Planus

NCT06451744 ·Status: RECRUITING ·Phase: NA

Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01710046 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3361237 in Participants With Psoriasis

NCT04975295 ·Status: COMPLETED ·Phase: PHASE1

Brodalumab in Palmoplantar Psoriasis

NCT04622033 ·Status: UNKNOWN ·Phase: PHASE4

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT06176768 ·Status: COMPLETED ·Phase: PHASE2

Single Ascending Dose Study of PRX003 in Healthy Subjects

NCT02458677 ·Status: COMPLETED ·Phase: PHASE1

Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.

NCT07492251 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2